SEC Form 4 · accession 0001645627-18-000033
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Jun 6, 2018
Accepted (ET)
Jun 14, 2018 · 11:59 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 6, 2018 | P | 1,000 | $0.0368 | A | 25,148,289 | D | |
| Common Stock | Jun 6, 2018 | P | 1,000 | $0.0368 | A | 25,149,289 | D | |
| Common Stock | Jun 7, 2018 | P | 1,000 | $0.0413 | A | 25,150,289 | D | |
| Common Stock | Jun 7, 2018 | P | 1,000 | $0.0387 | A | 25,151,289 | D | |
| Common Stock | Jun 8, 2018 | P | 1,000 | $0.0376 | A | 25,152,289 | D | |
| Common Stock | Jun 8, 2018 | P | 1,000 | $0.037 | A | 25,153,289 | D | |
| Common Stock | Jun 11, 2018 | P | 1,000 | $0.0395 | A | 25,154,289 | D | |
| Common Stock | Jun 11, 2018 | P | 1,000 | $0.0385 | A | 25,155,289 | D |
Table II — derivative securities
No Table II lines on this filing.